Completed NA INTERVENTIONAL 2-arm NCT00934336

Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention (ITOPOS)

Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Interventions Therapeutic and preventive strategies

Updated 7 times since 2017 Last updated: Aug 5, 2015 Started: Nov 30, 2008 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Type 1 Diabetes, this trial is completed. The trial is conducted by Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Sep 2020 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Data source: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Corbeil-Essonnes, France